Urgent notice: Bivalent mRNA COVID-19 vaccines are no longer authorized

NCPA September 13, 2023

The FDA has authorized updated COVID-19 mRNA vaccines for 2023-2024. Pharmacies that have been offering bivalent mRNA COVID-19 vaccines should immediately cease administering these products due to FDA withdrawing authorization. More information is available on the FDA website. When submitting claims for dates of service prior to the withdrawal, double check the submitted date. Note that FDA has not yet authorized or approved an updated Novavax vaccine for 2023-2024. As a result, the existing Novavax vaccine may still be administered at this time if it is determined that the individual should not wait for a 2023-2024 Novavax COVID-19 vaccine.